• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ESBF3614C103E
Device Problems Leak/Splash (1354); Material Deformation (2976)
Patient Problem Obstruction/Occlusion (2422)
Event Date 04/17/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
An endurant iis stent graft system was implanted during the endovascular treatment of a 48mm rapid expanding abdominal aortic aneurysm.The diameter of the aorta at the proximal renal artery was noted as 29mm and 28 distal with a neck length of 20mm.The ima was coiled during the procedure.It was reported during the index procedure, multiple images of the renal arteries were taken and esbf3614c103e was landed precisely below the left accessory renal artery.Right after deployment, it was noted that the gate was not fully open and appeared to be kinked.Multiple attempts to canulate the gate with non-mdt catheters and a tourguide failed.The physician decided to complete the deployment and snare the wire.The device was removed and a long 16fr sheath was placed in the ipsilateral limb.Using a tourguide and 16fr sheath the wire was snared and pulled out from the left groin.The wires on the right and left were exchanged for non-mdt stiff wire.A reliant balloon was used to balloon at the gate to make 100% sure the position was at the gate.Left side deployment of etlw1613c156e was completed first as it was the gate side and the right side extended with etlw1613c146e.A reliant balloon was placed up the right side.Immediately upon ballooning the graft, the proximal graft markers were seen to move.3 markers moved to the patients right side.A second balloon was placed up simultaneously to balloon the main body.Both balloons were ballooned to make sure the supra renal stents were not stuck together and it was confirmed they were not.Ballooning was started at the bottom and worked up the graft as well as worked from top down to try to iron out the graft.Final run saw a proximal type ia endoleak.Ballooning was completed again with ivus.Esbf3614c103e was seen under ivus folded right down the center of the graft looking like two barrels.After ballooning another angiogram was taken to see if had resolved.The angiogram once again showed a big type i endoleak.After discussing options an aortic cuff (etcf3636c49) was placed successfully from the left with the left accessory renal artery sacrificed.A reliant balloon was used to mold the cuff out.Ivus was put back up and the graft was visualized to be fully opposed to the wall with no folding.One last final angiogram was preformed which showed the type ia endoleak was resolved.The patient was alert and awake on transfer to icu post op, per the physician the cause of the type ia endoleak and infolding is undetermined.No additional clinical sequelae were reported, and the patient is fine.
 
Manufacturer Narrative
It was confirmed that no vessel calcium or vessel thrombus that would have caused this issue.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19134877
MDR Text Key340505254
Report Number9612164-2024-01876
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00643169439955
UDI-Public00643169439955
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberESBF3614C103E
Device Catalogue NumberESBF3614C103E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/18/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/17/2024
Initial Date FDA Received04/18/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/19/2024
Date Device Manufactured02/07/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexMale
-
-